Weekly signal · RVMD · Healthcare

Revolution Medicines Inc (RVMD) extends 12-week biotech surge to 96.2%

The oncology developer’s weekly setup remains firm, with trend and relative-strength readings supportive while volume confirmation is below average.

Revolution Medicines Inc
Latest189.24 USD
1W move3.9%
Volume0.9x
TrendActive
Weekly market chart concept for Revolution Medicines with biotechnology research imagery.

Market update

What happened

Revolution Medicines Inc (RVMD) closed the latest week at 189.24 USD, rising 3.9% and extending its four-week gain to 26.8%. The chart is a weekly price path over 52 weeks, framing the move as a sustained medium-term advance rather than live intraday action.

Confirmation is constructive but not clean. The trend signal is active, Relative Strength is high at 87.6, and Market Dynamics show positive pressure at 1.15, while volume ran below normal at about 0.6x on the weekly setup screen.

Continue your research

Explore RVMD across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

RVMD coverage

Evidence context